Daniel Shevrin to Neoplasm Staging
This is a "connection" page, showing publications Daniel Shevrin has written about Neoplasm Staging.
Connection Strength
0.074
-
Brief assessment of priority symptoms in hormone refractory prostate cancer: the FACT Advanced Prostate Symptom Index (FAPSI). Health Qual Life Outcomes. 2003 Nov 21; 1:69.
Score: 0.041
-
Phase I/II trial of orteronel (TAK-700)--an investigational 17,20-lyase inhibitor--in patients with metastatic castration-resistant prostate cancer. Clin Cancer Res. 2014 Mar 01; 20(5):1335-44.
Score: 0.021
-
Phase I/II trial of vinorelbine and divided-dose carboplatin in advanced non-small cell lung cancer. Lung Cancer. 2003 Feb; 39(2):221-6.
Score: 0.010
-
A phase II study of Adriamycin in previously untreated squamous cell carcinoma of the head and neck. Cancer. 1985 Dec 01; 56(11):2573-5.
Score: 0.003